Back to Search
EFREN MORENO, M.D.
M.D.
Specialist
NPI: 1679560817Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
PMID 19584289·Cancer Res·2009
7-preclinical
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
PMID 19584287·Cancer Res·2009
7-preclinical
Recurring eczema during pregnancy and after delivery due to sensitization caused by an ultrasound gel.
PMID 19565530·Ultrasound Obstet Gynecol·2009
5-case
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
PMID 19553897·Molecules·2009
7-preclinical
The differential interaction of Brucella and ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens.
PMID 19529776·PLoS One·2009
7-preclinical
Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
PMID 19479801·Liver Transpl·2009
8-other
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.
PMID 19413572·Br J Pharmacol·2009
8-other
Serological diagnosis of Brucella infections in odontocetes.
PMID 19386800·Clin Vaccine Immunol·2009
4-observational
The co-regulator dNAB interacts with Brinker to eliminate cells with reduced Dpp signaling.
PMID 19270172·Development·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6999 MCPHERSON RD, SUITE 110
LAREDO, TX 78041 - Phone
- (956) 722-8263
Quick Facts
- NPI
- 1679560817
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile